Sahajanand Medical Technologies has set a ₹327, 344 price band for its IPO of 1.38 crore shares. At the upper end, the offer would raise about ₹475.5 crore and value the cardiovascular-device maker at roughly ₹3,500 crore.

The issue is entirely an offer for sale by promoters and existing investors, so the company will not receive the proceeds. Subscription opens on 15 October and closes on 19 October, after the anchor book opens on 14 October. Allotment is expected on 21 October, with listing planned for 23 October.

Excluding the employee reservation, 50% of the net offer is allocated to qualified institutional buyers, 15% to non-institutional investors and 35% to retail investors. These are announced offer terms, not an investment recommendation.